PPAR inhibitor, Imiglitazar, Purity ≥98%

Cat. No.: X24-08-YM462

PPAR inhibitor, Imiglitazar, Purity ≥98%

Synonym: 250601-04-8; TAK-559; TAK559; TAK 559; (4E)-4-[[4-[(5-Methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methoxyimino]-4-phenylbutanoic acid

  • CAS Number: 250601-04-8
  • Compound CID: 9890879
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Imiglitazar is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PPAR. It targets the PPARα and PPARγ1.
Molecular Weight
470.52
Molecular Formula
C28H26N2O5
Targets
PPARα: 67 nM (EC50); PPARγ1: 31 nM (EC50)
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Imiglitazar is a metabolism inhibitor that plays a key role in research for its potential to treat type 2 diabetes by improving insulin sensitivity and glucose regulation.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0